Alison Lunsford
Pediatric Endocrinology · Columbia, SCNPI 1184824286
Payments from drug & device makers
Across 792 payments — averaging $304.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rhythm Pharmaceuticals, Inc.$131K
- Novo Nordisk AS$48K
- Eli Lilly$36K
- Biomarin Pharmaceutical Inc.$19K
- Sanofi-aventis U.S. LLC$4K
- AstraZeneca$900
- plus $3K from 27 others
Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$16
What the payments were for
- Consulting fees$9007%
- Speaking & faculty fees$7,89060%
- Travel & lodging$1,37410%
- Food & beverage$2,93422%
- Education$320%
- Entertainment$961%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rhythm Pharmaceuticals, Inc. | 76 | $131,175 |
| Novo Nordisk AS | 638 | $48,064 |
| Eli Lilly | 1 | $36,293 |
| Biomarin Pharmaceutical Inc. | 3 | $18,616 |
| Sanofi-aventis U.S. LLC | 5 | $3,594 |
| AstraZeneca | 1 | $900 |
| Kyowa Kirin, Inc. | 4 | $482 |
| BETA Bionics, Inc. | 6 | $271 |
| Ascendis Pharma Endocrinology Inc | 4 | $240 |
| Tolmar, Inc. | 6 | $206 |
| Insulet Corporation | 5 | $164 |
| Organogenesis Inc. | 2 | $150 |
| Smith+Nephew | 1 | $111 |
| Ultragenyx Pharmaceutical Inc. | 1 | $106 |
| Sequel Med Tech, LLC | 2 | $99 |
| Optos, Inc. | 1 | $96 |
| Medtronic(2 entities) | 2 | $90 |
| Pfizer | 4 | $87 |
| Tandem Diabetes Care, Inc. | 4 | $67 |
| Novo Nordisk | 3 | $63 |
| Abbott | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| AbbVie | 2 | $50 |
| Endo USA, Inc. | 2 | $48 |
| Amphastar Pharmaceuticals, Inc. | 2 | $44 |
| Dexcom, Inc. | 2 | $42 |
| Tolmar Pharmaceuticals, Inc. | 2 | $40 |
| Eton Pharmaceuticals, Inc. | 2 | $38 |
| Soleno Therapeutics, Inc. | 1 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Imcivree$938
- Strensiq$900
- CRYSVITA$588
- iLet Bionic Pancreas$418
- iLet Insulin Infusion Kit Inset$139
- iLet Insulin Infusion Kit Contact Detach$139
- PURAPLY WOUND MATRIX$125
- FENSOLVI$114
- GRAFIX PL$111
- TZIELD$104
How this compares
Too few pediatric endocrinology providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Columbia
- Lisa KnightColumbia$80K
- Whitney BrownColumbia$2K
- Bhavana NaralaColumbia$1K
- Elaine AppersonGreenville$136K
- Deborah BowlbyCharleston$21K
- Tarina MendesSeneca$5K
- Deidre McSweeny-TysonFlorence$3K
- Ryan DyessGreenville$2K
- Katherine LewisGreenville$2K
- Melissa GargantaGreenville$925
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.